On 16 December 2014, orphan designation (EU/3/14/1397) was granted by the European Commission to PlumeStars s.r.l., Italy, for amikacin sulfate for the treatment of Pseudomonas aeuriginosa lung infections in cystic fibrosis.
|Disease / condition||
Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.